Abstract:Introduction Long intergenic non-protein-coding RNA 1296 (LINC01296), a newly identified lncRNA, can function as an oncogenic driver to promote the development of multiple carcinomas. However, the effect of LINC01296 on oral squamous cell carcinoma (OSCC) is still unclear. Material and methods We determined the expression and role of LINC01296 in OSCC tissues and cell lines. The cell viability, migration and invasion were determined by MTT, wound healing assay and transwell assay, respectively. Flow cytometry was used for detecting cell cycle and apoptosis. The interaction and association between LINC01296, microRNA-485-5p (miR-485-5p) and p21 (RAC1) activated kinase 4 (PAK4) were analyzed by RNA immunoprecipitation (RIP) and luciferase reporter assays. The xenograft mouse model was established to detect the effect of LINC01296 on OSCC tumor growth. Results Our study showed that LINC01296 was over-expressed in OSCC tissues and cell lines. The level of LINC01296 was positively correlated with the patient’s tumor node metastasis (TNM) stage and nodal invasion. Knockdown of LINC01296 effectively inhibits cell viability, migration and invasion but promotes cell apoptosis in vitro. The in vivo experiment showed that LINC01296 knockdown inhibited OSCC tumor growth. The following analysis indicated that LINC01296 acted as a ceRNA for miR-485-5p, and PAK4 was identified as a direct target of miR-485-5p. Furthermore, we found that the effects of LINC01296 on OSCC progression were through regulating the expression of PAK4/p-MEK/p-ERK via sponging miR-485-5p. Conclusions LINC01296 promote the cell cycle, proliferation, migration and invasion, and inhibit apoptosis of OSCC cells through activating the MAPK/ERK signaling pathway via sponging miR-485-5p to regulate PAK4 expression. These results suggested that the LINC01296/miR-485-5p/PAK4 axis was closely associated with OSCC progression. Our study provides a new insight into the molecular pathogenesis of OSCC, and may supply novel biomarkers for diagnosis and therapy of OSCC.

MicroRNA-191 regulates oral squamous cell carcinoma cells growth by targeting PLCD1 via the Wnt/β-catenin signaling pathway

Downregulation of Microrna 99a in Oral Squamous Cell Carcinomas Contributes to the Growth and Survival of Oral Cancer Cells.

miR-223 regulates oral squamous cell carcinoma metastasis through the Wnt/β-catenin signaling pathway

Long Non-Coding RNA LINC01296 Promotes Progression of Oral Squamous Cell Carcinoma Through Activating the MAPK/ERK Signaling Pathway Via the Mir-485-5p/pak4 Axis

MicroRNA-191 Modulates Cisplatin-Induced DNA Damage Response by Targeting RCC2.

Screening and identification of miR-181a-5p in oral squamous cell carcinoma and functional verification in vivo and in vitro

MicroRNA‐191 promotes hepatocellular carcinoma cell proliferation by has_circ_0000204/miR‐191/KLF6 axis

MicroRNA-140-5p Targets Insulin Like Growth Factor 2 Mrna Binding Protein 1 (IGF2BP1) to Suppress Cervical Cancer Growth and Metastasis.

MiR-146a-5p Inhibits Proliferation and Promotes Apoptosis of Oral Squamous Cell Carcinoma Cells by Regulating NF-κB Signaling Pathway

Purification and characterisation of a novel cysteine conjugate beta-lyase from the tapeworm Moniezia expansa.

Transoesophageal echocardiography--an overview.

Identification of key miRNAs and targeted genes involved in the progression of oral squamous cell carcinoma

Long Noncoding RNA ZEB1-AS1 Downregulates miR-23a, Promotes Tumor Progression, and Predicts the Survival of Oral Squamous Cell Carcinoma Patients

MiR-195 Enhances the Sensitivity of Oral Cancer Cells to Cisplatin (DDP) by Down-Regulating the Expression of MAPK Kinase 1 (MEK1)

Circ_0001461 Promotes Oral Squamous Cell Carcinoma Progression Through Mir-145/Tlr4/nf-κb Axis

MicroRNA-144-3p Inhibits Tumorigenesis of Oral Squamous Cell Carcinoma by downregulating ERO1L

Mirna-101 Acts As a Tumor Suppressor in Oral Squamous Cell Carcinoma by Targeting CX Chemokine Receptor 7.

MiR-193a-3p Inhibits Pancreatic Ductal Adenocarcinoma Cell Proliferation by Targeting CCND1.

miRNA‐192 and ‐215 activate Wnt/β‐catenin signaling pathway in gastric cancer via APC

Downregulation of miR-503 Promotes ESCC Cell Proliferation, Migration, and Invasion by Targeting Cyclin D1.

Downregulation of miR-221/222 by a microRNA sponge promotes apoptosis in oral squamous cell carcinoma cells through upregulation of PTEN